Aquestive Therapeutics (AQST) Receivables - Net (2017 - 2026)
Aquestive Therapeutics (AQST) posted Receivables - Net of $9.33 million for Q2 2026, down 21.4% from $11.86 million a year earlier but up 35.8% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Receivables - Net (2017 - 2026) Analysis & Trends
At the end of FY2025, Aquestive Therapeutics' Receivables - Net came in at $17.76 million, up 141.9% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
- In prior years, Aquestive Therapeutics' Receivables - Net was $7.34 million in FY2024 (-13.3%), $8.47 million in FY2023 (+80.1%), $4.7 million in FY2022 (-61.2%) and $12.12 million in FY2021 (+74.3%).
- Quarterly Receivables - Net has run from a low of $4.7 million in Q4 2022 to a high of $19.9 million in Q1 2022 over five years.
- On a year-over-year basis, Receivables - Net increased in five of the last eight quarters, with growth averaging 28.9%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q4 2025, with growth of 141.9%; the weakest was Q1 2023, with a decline of 62.0%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $6.87 million (Q1 2026), $17.76 million (Q4 2025) and $11.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aquestive Therapeutics | 596.18 Mn | 136.72 Mn | 9.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 6.87 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 11.86 Mn |
| Mar 31, 2025 | 10.44 Mn |
| Dec 31, 2024 | 7.34 Mn |
| Sep 30, 2024 | 9.68 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 8.32 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 8.55 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 7.55 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Sep 30, 2022 | 10.74 Mn |
| Jun 30, 2022 | 19.17 Mn |
| Mar 31, 2022 | 19.90 Mn |
| Dec 31, 2021 | 12.12 Mn |
| Sep 30, 2021 | 13.64 Mn |
API Access
Aquestive Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();